Greenphire Signs Enterprise Agreement with Top 20 Biopharmaceutical Company

KING of PRUSSIA, PA (June 25, 2012) – Greenphire, the leading provider of clinical payment technology and service solutions to Biopharmaceutical and medical device companies, today announced it has signed a 5-year enterprise agreement with a top 20 Biopharmaceutical Sponsor for its eClinicalGPS solution.

The eClinicalGPS solution will allow the Sponsor to fully automate the calculation, approval and execution of payments to clinical research sites in over 200 countries in local currency.  The solution will be deployed across all new and existing studies.  Beyond the immediate need to more effectively manage the payment process, improve efficiency, reduce costs and provide a single source for clinical financial analytics, the solution also provides the platform on which to aggregate all site payment in preparation for the compliance requirements of the Sunshine Act and related international transparency regulation.

Greenphire Co-founder and Chief Executive Officer Sam Whitaker, commented, “this agreement represents the beginning of a significant change in the way Sponsors think about the payment process within the clinical trial environment. Our vision of applying well designed, automated and scalable technology to a process which has historically relied on manual processes is driving positive change. We are reducing administrative burden, reducing payment cycle times and improving accuracy.”

About Greenphire:

Greenphire is the industry’s leading provider of clinical payment technology, designed to change the way research professionals work. The company leverages proprietary workflow automation and advanced web‐based payment technologies to enable users to improve operational efficiency, reduce costs, mitigate regulatory risks, increase subject retention and compliance, and produce quantifiable results that improve clinical operations and strategic planning. For additional information about the company, please visit www.greenphire.com.

Greenphire Launches Unique ‘Site Payment Solution’ to Facilitate Sponsor Compliance with Physician Payment Sunshine Act

Philadelphia, PA, (7 July 2011). Greenphire, the industry leading provider of clinical payment and communication technology solutions, has announced the launch of its Clinical GPS technology, a unique site payment solution that streamlines and automates the clinical payment process for sponsors of all sizes. The system provides the ultimate solution for compliance with the recently passed federal Physician Payment Sunshine Act, enabling clients to make the required disclosures and reports effortlessly.

Greenphire Partners with Mytrus to Provide Web-Based Solutions that Revolutionize Patient Recruitment and Retention, Enhancing Study Efficiency

Philadelphia, PA, (16 June, 2011). Greenphire, the industry leading provider of clinical payment and communication technology solutions, has announced the partnership with Mytrus to deliver novel and efficient web-based solutions for clinical trial patients. In an industry characterized by timeless corporate giants like Johnson & Johnson, Pfizer, and Merck, two young technology companies are partnering to transform the clinical research environment.  Recognizing longstanding deficiencies in the traditional clinical trials process, Greenphire LLC, based in Philadelphia and San Francisco startup Mytrus Inc. have developed web-based solutions to streamline the arduous and expensive tasks of recruiting, retaining, and efficiently administering clinical trials.  Greenphire’s ClinCard System, a web-based patient payment, management and communication platform, compliments the functionality offered by Mytrus and its innovative methods for allowing patients to participate in clinical research studies directly from their own homes.

By revolutionizing the clinical research process with these new technologies, Greenphire and Mytrus hope to empower patients to play a larger and more critical role in pharmaceutical development.  In contrast to the traditional environment in which patients have often needed to repeatedly travel long distances to be evaluated by participating medical centers, Mytrus allows patients to use innovative web technology to provide their own study data over the internet and then be immediately compensated directly to a Greenphire ClinCard debit card the patient carries around in their wallet.

In Shifting Regulatory Climate Greenphire Unveils Latest Clinical Payment Solutions at DIA 2011

Pennsylvania, (07 June 2011) Greenphire, the industry leading provider of clinical payment and communication technology solutions, will showcase its ground breaking clinical payment solutions including ClinCard, an automated payment and communications system and its new ClinicalGPS technology at the annual DIA 2011 symposium in Chicago, Illinois, June 19th to 23rd. To find out more, visit the company at booth #231 at DIA 2011.

Despite the fact that a significant proportion of the adult American population does not possess a bank account, clinical trial sponsors have relied upon costly and time consuming paper checks for subject payment.
Greenphire offers a cost effective, easy-to-use alternative to these traditional paper-based payment methods, promoting recruitment and aiding subject retention both through efficient delivery of funds and the associated execution of study specific subject messaging programs.